You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

56 Results
Guidelines and Advice
Status: Archived
ID: 3-8-1
Apr 2013
Guidelines and Advice
Status: Archived
ID: 3-8-2
Version: 2
Sep 2011
Guidelines and Advice
Status: Archived
ID: 6-17
Nov 2013
Guidelines and Advice
Status: Archived
ID: 6-19
Jan 2007
Guidelines and Advice
Status: Archived
ID: 11-4
Sep 2011
Guidelines and Advice
Status: Archived
ID: 43096
Feb 2018
Guidelines and Advice
Status: Current
ID: GL-C50-22
Oct 2015
Guidelines and Advice
Status: Current
Jun 2017
Guidelines and Advice
Status: Current
ID: GL-C50-16
Jun 2014
Regimen
Cancer Type:
Skin, 
Melanoma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Ipilimumab - Previously Untreated Advanced Unresectable Melanoma
New Drug Funding Program
    Ipilimumab - Previously Treated Advanced Unresectable Melanoma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
ipilimumab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2024
The Immune Checkpoint Inhibitor Toxicity Management Toolkit has been designed to help support individuals taking immune checkpoint inhibitor...
Regimen
Cancer Type:
Hematologic, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
ixazomib (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
May 2019

Pages